UPDATE 5-Lilly's drug for Alzheimer's fails big trial; shares drop
Nov 23 (Reuters) - Eli Lilly and Co said its experimental Alzheimer's treatment failed to slow the loss of mental functioning in patients with mild symptoms, a major setback for the company and... [Source]
Publication Date:Origin: reuters.com
Category: hotStocksNews
Topics: Alzheimer's, company, major setback, symptoms, patients, functioning, of mental, failed, treatment, its experimental, Lilly, (Reuters), shares, trial;, fails, 5-Lilly's, UPDATE
